| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $303K | -55.6% |
| SG&A Expense | $437K | +6261.9% |
| Operating Income | -$740K | -624.3% |
| Interest Expense | -$3K | -160.0% |
| Net Income | -$778K | -661.1% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8K | -92.5% |
| Accounts Receivable | $43K | -39.4% |
| Current Assets | $51K | -52.4% |
| Total Assets | $323K | +201.7% |
| Current Liabilities | $348K | +531.1% |
| Total Liabilities | $397K | +619.9% |
| Stockholders' Equity | -$74K | -242.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$617K | -835.8% |
| Investing Cash Flow | -$23K | +63.5% |
| Financing Cash Flow | $621K | +259.0% |